FDMT
4D Molecular Therapeutics Inc
14.50$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.1% | – | -82.1% | -40.0% | -66.7% | +1,300.0% | +7.1% | +500.0% | +94,444.4% | -96.4% | +24.1% | – | |
| – | +3.8% | +7.1% | +14.3% | +20.8% | -95.4% | +2,181.3% | +17.8% | -1.5% | -95.8% | +3.8% | +1.7% | – | |
| – | – | – | – | – | – | – | – | – | – | -98.8% | +70.6% | – | |
| – | +3.8% | +7.1% | +14.3% | +20.8% | +12.0% | -5.5% | +17.8% | +3.1% | +16.5% | +12.8% | +5.1% | – | |
| – | +16.4% | -2.9% | +3.0% | +19.3% | +3.0% | -0.7% | -10.9% | +2.8% | +7.9% | -8.5% | +7.2% | – | |
| – | +16.4% | -2.9% | +3.0% | +19.3% | +329.5% | -76.2% | -10.9% | +21.8% | +387.2% | +9.1% | +5.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -600.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -454.5% | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -454.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -638.6% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.